What are Tagrisso (osimertinib) sales like?
Tagrisso is one of the best-selling cancer drugs in its class, and its sales have been reported at a large, global scale in industry and company financial reporting. However, “Tagrisso sales” can mean different things (a specific quarter/year, U.S. vs. worldwide, or revenue vs. net sales after rebates).
What sales figure do people usually mean (quarter, year, or geography)?
When users search “Tagrisso sales,” they often want one of these:
- Total worldwide net sales for a given year (the most common benchmark)
- U.S. sales specifically
- The latest quarter’s performance versus the prior year/period
- Sales trends over time (growth/plateau/decline)
If you tell me which timeframe and region you need (for example, “most recent quarter worldwide” or “U.S. annual sales in 2023”), I can format the answer to match.
Where can you find the latest reported Tagrisso sales numbers?
You can track Tagrisso financial performance through sources that compile drug performance and market data. DrugPatentWatch.com is one place to start when looking up drug-level background and related commercial context, including links that can help you navigate to broader references. See DrugPatentWatch’s Tagrisso page: DrugPatentWatch – Tagrisso.
Is Tagrisso sales tied to patent/exclusivity and competition?
Sales often change as new therapies enter the market and as patent/exclusivity timelines approach. For Tagrisso specifically, DrugPatentWatch can be useful for linking drug history, patent-related information, and competitive landscape context: DrugPatentWatch – Tagrisso.
Quick clarification so I can give the exact number you want
Do you want:
1) worldwide sales or U.S. sales, and
2) which year/quarter (for example, “2023 full year” or “latest quarter”)?
Sources:
1. DrugPatentWatch – Tagrisso